Literature DB >> 25933742

Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.

Bohyun Kim1,2, Jae Ho Byun3, Hyoung Jung Kim1, Hyung Jin Won1, So Yeon Kim1, Yong Moon Shin1, Pyo Nyun Kim1.   

Abstract

OBJECTIVES: To compare the enhancement patterns and prevalence of pseudo-washout between rapidly and slowly enhancing hepatic haemangiomas on gadoxetate disodium-enhanced MRI in patients with chronic liver disease (CLD) and healthy liver (HL).
METHODS: On gadoxetate disodium-enhanced MRI, the extent of intralesional arterial enhancement >50 % and ≤ 50 % of lesions was defined as rapid and slow enhancement, respectively. The enhancement patterns and presence of pseudo-washout during the portal venous phase (PVP) and transitional phase (TP) of 74 hepatic haemangiomas were retrospectively evaluated in the CLD and HL groups. Sequential changes of signal-to-noise ratio (SNR) were measured in unenhanced phase, PVP and TP.
RESULTS: Irrespective of hepatic health status, pseudo-washout in TP was significantly more common in the rapidly enhancing haemangiomas (p ≤ 0.026). In both groups, rapidly enhancing haemangiomas showed complete or progressive incomplete enhancement in PVP, which either lasted or transformed to pseudo-washout in TP, whereas slowly enhancing haemangiomas showed progressive incomplete enhancement in PVP and TP. SNR of hepatic parenchyma continued to rise until TP, whereas that of portal vein and haemangioma falls in TP.
CONCLUSIONS: Regardless of CLD, pseudo-washout in TP was more common in rapidly than in slowly enhancing haemangiomas, with enhancement patterns differing in the two subgroups. KEY POINTS: On gadoxetate disodium-enhanced MRI, some hepatic haemangiomas show pseudo-washout in transitional phase. Regardless of chronic liver disease, pseudo-washout is significantly more common in rapidly enhancing haemangiomas. Rapidly enhancing haemangiomas show complete or progressive incomplete enhancement or pseudo-washout in TP. Slowly enhancing haemangiomas show progressive incomplete enhancement in portal venous phase and TP.

Entities:  

Keywords:  Gadoxetate disodium; Haemangioma; Liver; Magnetic resonance imaging; Pseudo-washout

Mesh:

Substances:

Year:  2015        PMID: 25933742     DOI: 10.1007/s00330-015-3798-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Diagnostic approach to hepatic hemangiomas.

Authors:  R C Nelson; J L Chezmar
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

2.  Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.

Authors:  P Soyer; A C Dufresne; E Somveille; A Scherrer
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

3.  Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT.

Authors:  B A Birnbaum; J C Weinreb; A J Megibow; J J Sanger; E Lubat; H Kanamuller; M E Noz; M A Bosniak
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

4.  Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Ai Ueki; Akihiko Kanki; Atsushi Higaki; Hiroki Higashi; Akira Yamamoto
Journal:  J Magn Reson Imaging       Date:  2011-11-29       Impact factor: 4.813

5.  Prediction rule for characterization of hepatic lesions revealed on MR imaging: estimation of malignancy.

Authors:  R Tello; H M Fenlon; T Gagliano; V L deCarvalho; E K Yucel
Journal:  AJR Am J Roentgenol       Date:  2001-04       Impact factor: 3.959

6.  Imaging of atypical hemangiomas of the liver with pathologic correlation.

Authors:  V Vilgrain; L Boulos; M P Vullierme; A Denys; B Terris; Y Menu
Journal:  Radiographics       Date:  2000 Mar-Apr       Impact factor: 5.333

7.  Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings.

Authors:  Y Yamashita; I Ogata; J Urata; M Takahashi
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

8.  "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.

Authors:  Kyung Won Doo; Chang Hee Lee; Jae Woong Choi; Jongmee Lee; Kyeong Ah Kim; Cheol Min Park
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

9.  Discrimination of benign from malignant hepatic lesions based on their T2-relaxation times calculated from moderately T2-weighted turbo SE sequence.

Authors:  Andrzej Cieszanowski; Wojciech Szeszkowski; Marek Golebiowski; Dennis K Bielecki; Mariusz Grodzicki; Bogdan Pruszynski
Journal:  Eur Radiol       Date:  2002-04-18       Impact factor: 5.315

10.  MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.

Authors:  P Soyer; C Gueye; E Somveille; J P Laissy; A Scherrer
Journal:  AJR Am J Roentgenol       Date:  1995-12       Impact factor: 3.959

View more
  7 in total

1.  Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Authors:  Qi Tang; Cong Ma
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

2.  Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?

Authors:  Kyoung A Baek; Seung Soo Kim; Hyeong Cheol Shin; Jeong Ah Hwang; Seo-Youn Choi; Woong Hee Lee; Chan Ho Park; Hyoung Nam Lee; Nam Hun Heo
Journal:  Abdom Radiol (NY)       Date:  2020-09

Review 3.  Imaging of hepatic hemangioma: from A to Z.

Authors:  Giuseppe Mamone; Ambra Di Piazza; Vincenzo Carollo; Christine Cannataci; Kelvin Cortis; Tommaso Vincenzo Bartolotta; Roberto Miraglia
Journal:  Abdom Radiol (NY)       Date:  2020-03

Review 4.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

5.  Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command.

Authors:  Andreas Gutzeit; Simon Matoori; Johannes M Froehlich; Constantin von Weymarn; Carolin Reischauer; Orpheus Kolokythas; Matthias Goyen; Klaus Hergan; Matthias Meissnitzer; Rosemarie Forstner; Jan D Soyka; Aleksis Doert; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2015-11-16       Impact factor: 5.315

Review 6.  Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.

Authors:  Jae Hyun Kim; Ijin Joo; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

Review 7.  Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.

Authors:  Yeun-Yoon Kim; Mi-Suk Park; Khalid Suliman Aljoqiman; Jin-Young Choi; Myeong-Jin Kim
Journal:  Clin Mol Hepatol       Date:  2019-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.